FINISHED DOSAGE PORTFOLIO

Formulations built around real procurement needs.

Explore Decure’s sourcing portfolio across injectables, tablets, capsules, dry syrups, topical formulations and specialized therapeutic ranges, with multiple strengths, compositions and dosage-form options for institutional and commercial requirements.

91
Product masters
697
Active variants
Multiple
Dosage forms
Pharmaceutical formulation manufacturing and quality review
Specification-led reviewStrength · dosage form · quantity · documentation

PRODUCT FINDER

Find the right formulation

Reset
RFQ List (0)

Therapeutic Ranges

91 products available

Page 2 of 4
Diabetic Range
TabletSingle ingredient

Glimepiride Img Tab. (Uncoated)

Glimepiride Img Tab. (Uncoated) is a tablet formulated with Glimepiride Img . ( ). The listed active ingredient profile is Glimepiride Img, placing the product in the oral antidiabetic category. The formulation contains one or more oral glucose-lowering m

Available strengths
Glimepiride Img . ( )
Diabetic Range
Bilayered TabletSingle ingredient

Glimepiride IP 0.5 mg + Metformin Hydrochloride 500 mg (Uncoated bilayered Tablet)

Glimepiride IP 0.5 mg + Metformin Hydrochloride 500 mg (Uncoated bilayered Tablet) is a bilayered tablet formulated with Glimepiride IP 0.5 mg + Metformin Hydrochloride 500 mg ( ). The listed active ingredient profile is Glimepiride; Metformin Hydrochlori

Available strengths
Glimepiride IP 0.5 mg + Metformin Hydrochloride 500 mg ( )
Diabetic Range
Bilayered TabletSingle ingredient

Glimepiride lmg, Metformin Hcl (Sustained Released) 50mg + Voglibose 0.2mg Tablets (Uncoated Bilayered)

Glimepiride lmg, Metformin Hcl (Sustained Released) 50mg + Voglibose 0.2mg Tablets (Uncoated Bilayered) is a bilayered tablet formulated with Glimepiride lmg, Metformin Hcl (Sustained Released) 50mg + Voglibose 0.2mg ( ). The listed active ingredient prof

Available strengths
Glimepiride lmg, Metformin Hcl (Sustained Released) 50mg + Voglibose 0.2mg ( )
Diabetic Range
Bilayered TabletSingle ingredient

Glimepiride lP 4 mg + Metformin IP 1000 mg (Uncoated bilayered Tablet)

Glimepiride lP 4 mg + Metformin IP 1000 mg (Uncoated bilayered Tablet) is a bilayered tablet formulated with Glimepiride lP 4 mg + Metformin IP 1000 mg ( ). The listed active ingredient profile is Glimepiride lP; Metformin, placing the product in the oral

Available strengths
Glimepiride lP 4 mg + Metformin IP 1000 mg ( )
Diabetic Range
TabletSingle ingredient

Glimepirlde 3mg + Metformin Hydrochloride (SR ) 500mg

Glimepirlde 3mg + Metformin Hydrochloride (SR ) 500mg is a tablet formulated with Glimepirlde 3mg + Metformin Hydrochloride (SR ) 500mg. The listed active ingredient profile is Glimepirlde; Metformin Hydrochloride, placing the product in the oral antidiab

Available strengths
Glimepirlde 3mg + Metformin Hydrochloride (SR ) 500mg
Diabetic Range
TabletSingle ingredient

Glipizide 5 mg + Metformin 500 mg Tablets (Uncoated Tab)

Glipizide 5 mg + Metformin 500 mg Tablets (Uncoated Tab) is a tablet formulated with Glipizide 5 mg + Metformin 500 mg ( ). The listed active ingredient profile is Glipizide; Metformin, placing the product in the oral antidiabetic category. The formulatio

Available strengths
Glipizide 5 mg + Metformin 500 mg ( )
Diabetic Range
TabletSingle ingredient

Gllbenclamide 5mg, Mettorrmin Hydrochloride 500mg + Piogltazone Hydrochloride 15mg Tablet (ilm coated)

Gllbenclamide 5mg, Mettorrmin Hydrochloride 500mg + Piogltazone Hydrochloride 15mg Tablet (ilm coated) is a tablet formulated with Gllbenclamide 5mg, Mettorrmin Hydrochloride 500mg + Piogltazone Hydrochloride 15mg (ilm coated). The listed active ingredien

Available strengths
Gllbenclamide 5mg, Mettorrmin Hydrochloride 500mg + Piogltazone Hydrochloride 15mg (ilm coated)
Cardiac Range
TabletSingle ingredient

Ivabradine Hydrochloride 5mg Tab. (Film Coated)

Ivabradine Hydrochloride 5mg Tab. (Film Coated) is a tablet formulated with Ivabradine Hydrochloride 5mg . ( ). The listed active ingredient profile is Ivabradine Hydrochloride, placing the product in the antianginal / cardiovascular category. The active

Available strengths
Ivabradine Hydrochloride 5mg . ( )Ivabradine Hydrochloride 75mg . ( )
Cardiac Range
TabletSingle ingredient

Labetalol 100mg Tablets (Film coated)

Labetalol 100mg Tablets (Film coated) is a tablet formulated with Labetalol 100mg ( ). The listed active ingredient profile is Labetalol, placing the product in the antihypertensive / cardiovascular category. The formulation contains one or more cardiovas

Available strengths
Labetalol 100mg ( )
Diabetic Range
TabletSingle ingredient

Metformin 500mg Tab. (Uncoated)

Metformin 500mg Tab. (Uncoated) is a tablet formulated with Metformin 500mg . ( ). The listed active ingredient profile is Metformin, placing the product in the oral antidiabetic category. The formulation contains one or more oral glucose-lowering medicin

Available strengths
Metformin 500mg . ( )
Diabetic Range
TabletSingle ingredient

Metformin HCI (SR) 500mg

Metformin HCI (SR) 500mg is a tablet formulated with Metformin HCI (SR) 500mg. The listed active ingredient profile is Metformin HCI, placing the product in the oral antidiabetic category. The formulation contains one or more oral glucose-lowering medicin

Available strengths
Metformin HCI (SR) 500mgMetformin HCI (SR) 850mgMetformin HCI (SR) 1000mg
Diabetic Range
TabletSingle ingredient

Metformin Hydrochloride(as Prolonged Release Form ) 1000mg + Glimepiride 0.5mg

Metformin Hydrochloride(as Prolonged Release Form ) 1000mg + Glimepiride 0.5mg is a tablet formulated with Metformin Hydrochloride(as Form ) 1000mg + Glimepiride 0.5mg. The listed active ingredient profile is Metformin Hydrochloride; Glimepiride, placing

Available strengths
Metformin Hydrochloride(as Form ) 1000mg + Glimepiride 0.5mg
Cardiac Range
TabletSingle ingredient

Metoprolol Succinate 50 mg(ER) + Telmisartan 40mg Tab. (Film Coated)

Metoprolol Succinate 50 mg(ER) + Telmisartan 40mg Tab. (Film Coated) is a tablet formulated with Metoprolol Succinate 50 mg(ER) + Telmisartan 40mg . ( ). The listed active ingredient profile is Metoprolol Succinate; Telmisartan, placing the product in the

Available strengths
Metoprolol Succinate 50 mg(ER) + Telmisartan 40mg . ( )Metoprolol Succinate 25 mg (ER) + Telmisartan 40mg . ( )
Cardiac Range
TabletSingle ingredient

Metoprolol Succinate Prolonged Release Tablets IP 47.5 mg

Metoprolol Succinate Prolonged Release Tablets IP 47.5 mg is a tablet formulated with Metoprolol Succinate IP 47.5 mg. The listed active ingredient profile is Metoprolol Succinate, placing the product in the antihypertensive / cardiovascular category. The

Available strengths
Metoprolol Succinate IP 47.5 mgMetoprolol Succinate IP 23.7 mg
Cardiac Range
TabletSingle ingredient

Nebivolol 2.5mg + Cilnidipine 10mg Tablets (Film coated bilyered)

Nebivolol 2.5mg + Cilnidipine 10mg Tablets (Film coated bilyered) is a tablet formulated with Nebivolol 2.5mg + Cilnidipine 10mg ( bilyered). The listed active ingredient profile is Nebivolol; Cilnidipine, placing the product in the antihypertensive / car

Available strengths
Nebivolol 2.5mg + Cilnidipine 10mg ( bilyered)Nebivolol 5mg + Cilnidipine 10mg ( bilyered)
Cardiac Range
TabletSingle ingredient

Nebivolol Tablets IP 2.5MG (Uncoated)

Nebivolol Tablets IP 2.5MG (Uncoated) is a tablet formulated with Nebivolol IP 2.5MG ( ). The listed active ingredient profile is Nebivolol, placing the product in the antihypertensive / cardiovascular category. The formulation contains one or more cardio

Available strengths
Nebivolol IP 2.5MG ( )Nebivolol IP 5MG ( )
Cardiac Range
TabletSingle ingredient

Olmesartan 20mg + Hydrochlorothiazide 12.5 Tab. (Film Coated)

Olmesartan 20mg + Hydrochlorothiazide 12.5 Tab. (Film Coated) is a tablet formulated with Olmesartan 20mg + Hydrochlorothiazide 12.5 . ( ). The listed active ingredient profile is Olmesartan; Hydrochlorothiazide, placing the product in the antihypertensiv

Available strengths
Olmesartan 20mg + Hydrochlorothiazide 12.5 . ( )
Cardiac Range
TabletSingle ingredient

Olmesartan 40mg Tab. (Film Coated)

Olmesartan 40mg Tab. (Film Coated) is a tablet formulated with Olmesartan 40mg . ( ). The listed active ingredient profile is Olmesartan, placing the product in the antihypertensive / cardiovascular category. The formulation contains one or more cardiovas

Available strengths
Olmesartan 40mg . ( )
Cardiac Range
TabletSingle ingredient

Olmesartan Medoxomil 20mg + Amlodipine Besylate 5mg Tab. (Film Coated)

Olmesartan Medoxomil 20mg + Amlodipine Besylate 5mg Tab. (Film Coated) is a tablet formulated with Olmesartan Medoxomil 20mg + Amlodipine Besylate 5mg . ( ). The listed active ingredient profile is Olmesartan Medoxomil; Amlodipine Besylate, placing the pr

Available strengths
Olmesartan Medoxomil 20mg + Amlodipine Besylate 5mg . ( )Olmesartan Medoxomil 40mg + Amlodipine Besylate 5mg . ( )
Cardiac Range
TabletSingle ingredient

Olmesartan Medoxomil 40mg + Hydrochlorothiazide 12.5mg Tab. (Filrn Coated)

Olmesartan Medoxomil 40mg + Hydrochlorothiazide 12.5mg Tab. (Filrn Coated) is a tablet formulated with Olmesartan Medoxomil 40mg + Hydrochlorothiazide 12.5mg . (Filrn Coated). The listed active ingredient profile is Olmesartan Medoxomil; Hydrochlorothiazi

Available strengths
Olmesartan Medoxomil 40mg + Hydrochlorothiazide 12.5mg . (Filrn Coated)
Cardiac Range
TabletSingle ingredient

Olmesartan Medoxomil 40mg + Hydrochlorothiazide 25mg Tab. (Film Coated)

Olmesartan Medoxomil 40mg + Hydrochlorothiazide 25mg Tab. (Film Coated) is a tablet formulated with Olmesartan Medoxomil 40mg + Hydrochlorothiazide 25mg . ( ). The listed active ingredient profile is Olmesartan Medoxomil; Hydrochlorothiazide, placing the

Available strengths
Olmesartan Medoxomil 40mg + Hydrochlorothiazide 25mg . ( )
Cardiac Range
TabletSingle ingredient

Olmesartan Medoxomil 40mg + Ramipril 5mg Tab. (Film Coated)

Olmesartan Medoxomil 40mg + Ramipril 5mg Tab. (Film Coated) is a tablet formulated with Olmesartan Medoxomil 40mg + Ramipril 5mg . ( ). The listed active ingredient profile is Olmesartan Medoxomil; Ramipril, placing the product in the antihypertensive / c

Available strengths
Olmesartan Medoxomil 40mg + Ramipril 5mg . ( )
Cardiac Range
TabletSingle ingredient

Ramipril 2.5 mg Tab. Uncoated)

Ramipril 2.5 mg Tab. Uncoated) is a tablet formulated with Ramipril 2.5 mg . ). The listed active ingredient profile is Ramipril . ), placing the product in the antihypertensive / cardiovascular category. The formulation contains one or more cardiovascula

Available strengths
Ramipril 2.5 mg . )Ramipril 5 mg . ( )Ramipril 10 mg . (
Cardiac Range
TabletSingle ingredient

Rivaroxaban 2.5mg Tablet (film coated)

Rivaroxaban 2.5mg Tablet (film coated) is a tablet formulated with Rivaroxaban 2.5mg ( ). The listed active ingredient profile is Rivaroxaban, placing the product in the anticoagulant category. The active medicine reduces blood-clot formation through anti

Available strengths
Rivaroxaban 2.5mg ( )Rivaroxaban 5mg ( )Rivaroxaban 10mg ( ) +2
Cardiac Range
TabletSingle ingredient

Rosuvastatin 10 mg + Fenofibrate Tablets 160mg

Rosuvastatin 10 mg + Fenofibrate Tablets 160mg is a tablet formulated with Rosuvastatin 10 mg + Fenofibrate 160mg. The listed active ingredient profile is Rosuvastatin; Fenofibrate, placing the product in the lipid-lowering therapy category. The formulati

Available strengths
Rosuvastatin 10 mg + Fenofibrate 160mg
Add to RFQ

Ivabradine Hydrochloride 5mg Tab. (Film Coated)

Add to RFQ

Metformin HCI (SR) 500mg

Add to RFQ

Metoprolol Succinate 50 mg(ER) + Telmisartan 40mg Tab. (Film Coated)

Add to RFQ

Metoprolol Succinate Prolonged Release Tablets IP 47.5 mg

Add to RFQ

Nebivolol 2.5mg + Cilnidipine 10mg Tablets (Film coated bilyered)

Add to RFQ

Nebivolol Tablets IP 2.5MG (Uncoated)

Add to RFQ

Olmesartan Medoxomil 20mg + Amlodipine Besylate 5mg Tab. (Film Coated)

Add to RFQ

Ramipril 2.5 mg Tab. Uncoated)

Add to RFQ

Rivaroxaban 2.5mg Tablet (film coated)

FROM BRIEF TO SUPPLY

A clearer formulation sourcing process

01

Define

Share dosage form, strength, quantity and destination.

02

Review

We review availability and documentation expectations.

03

Coordinate

Commercial and supply requirements move forward together.

HUMAN FORMULATIONS

Turn your product list into one organised quotation request.

RFQ List (0)